{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:14:18Z","timestamp":1790021658907,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11912-019-0798-y","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T01:47:31Z","timestamp":1556329651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Alberto","family":"Falk Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayid","family":"Zommorodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Falk Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"798_CR1","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER). https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html . Accessed December 12 2018."},{"issue":"7","key":"798_CR2","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas N","year":"2015","unstructured":"Cancer Genome Atlas N. Genomic classification of cutaneous melanoma. cell. 2015;161(7):1681\u201396. https:\/\/doi.org\/10.1016\/j.cell.2015.05.044 .","journal-title":"cell."},{"issue":"7653","key":"798_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545(7653):175\u201380. https:\/\/doi.org\/10.1038\/nature22071 .","journal-title":"Nature."},{"issue":"5","key":"798_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","volume":"65","author":"CK Bichakjian","year":"2011","unstructured":"Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol American Academy of Dermatology. 2011;65(5):1032\u201347. https:\/\/doi.org\/10.1016\/j.jaad.2011.04.031 .","journal-title":"J Am Acad Dermatol American Academy of Dermatology"},{"issue":"5","key":"798_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","volume":"172","author":"A Breslow","year":"1970","unstructured":"Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902\u20138.","journal-title":"Ann Surg"},{"key":"798_CR6","unstructured":"Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington. 2008."},{"issue":"4","key":"798_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1308\/003588408X285856","volume":"90","author":"S Tadiparthi","year":"2008","unstructured":"Tadiparthi S, Panchani S, Iqbal A. Biopsy for malignant melanoma--are we following the guidelines? Ann R Coll Surg Engl. 2008;90(4):322\u20135. https:\/\/doi.org\/10.1308\/003588408X285856 .","journal-title":"Ann R Coll Surg Engl"},{"issue":"3","key":"798_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2003.106","volume":"48","author":"PC Ng","year":"2003","unstructured":"Ng PC, Barzilai DA, Ismail SA, Averitte RL Jr, Gilliam AC. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth? J Am Acad Dermatol. 2003;48(3):420\u20134. https:\/\/doi.org\/10.1067\/mjd.2003.106 .","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"798_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.amjsurg.2005.08.020","volume":"190","author":"RC Martin 2nd","year":"2005","unstructured":"Martin RC 2nd, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, et al. Is incisional biopsy of melanoma harmful? Am J Surg. 2005;190(6):913\u20137. https:\/\/doi.org\/10.1016\/j.amjsurg.2005.08.020 .","journal-title":"Am J Surg"},{"issue":"1","key":"798_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaad.2017.08.039","volume":"78","author":"RZ Conic","year":"2018","unstructured":"Conic RZ, Cabrera CI, Khorana AA, Gastman BR. Determination of the impact of melanoma surgical timing on survival using the National Cancer Database. J Am Acad Dermatol. 2018;78(1):40\u20136 e7. https:\/\/doi.org\/10.1016\/j.jaad.2017.08.039 .","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"798_CR11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/j.1098-2388.1993.tb00006.x","volume":"9","author":"AJ Sober","year":"1993","unstructured":"Sober AJ. Diagnosis and management of early melanoma: a consensus view. Semin Surg Oncol. 1993;9(3):194\u20137.","journal-title":"Semin Surg Oncol"},{"issue":"1","key":"798_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jaad.2013.01.040","volume":"69","author":"JH Kunishige","year":"2013","unstructured":"Kunishige JH, Brodland DG, Zitelli JA. Margins for standard excision of melanoma in situ. J Am Acad Dermatol. 2013;69(1):164. https:\/\/doi.org\/10.1016\/j.jaad.2013.01.040 .","journal-title":"J Am Acad Dermatol"},{"key":"798_CR13","unstructured":"Managing melanoma. National Institute for Health and Care Excellence. http:\/\/pathways.nice.org.uk\/pathways\/melanoma . 14 December 2018."},{"key":"798_CR14","doi-asserted-by":"publisher","unstructured":"Work G, Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2018. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.055 .","DOI":"10.1016\/j.jaad.2018.08.055"},{"key":"798_CR15","unstructured":"Malignt Melanom. Swedish National Treament Guidelines. Regional Cancer Centrum. 2017. http:\/\/www.cancercentrum.se Vr. 3.0. Accessed 16 May 2017."},{"issue":"7","key":"798_CR16","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO;2-D","volume":"89","author":"G Cohn-Cedermark","year":"2000","unstructured":"Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer. 2000;89(7):1495\u2013501.","journal-title":"Cancer."},{"issue":"8","key":"798_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/cncr.11272","volume":"97","author":"D Khayat","year":"2003","unstructured":"Khayat D, Rixe O, Martin G, Soubrane C, Banzet M, Bazex JA, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer. 2003;97(8):1941\u20136. https:\/\/doi.org\/10.1002\/cncr.11272 .","journal-title":"Cancer."},{"issue":"4","key":"798_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<272::AID-SSU2>3.0.CO;2-#","volume":"14","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N. Margin of resection in the management of primary melanoma. Semin Surg Oncol. 1998;14(4):272\u20135.","journal-title":"Semin Surg Oncol"},{"issue":"18","key":"798_CR19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJM198805053181804","volume":"318","author":"U Veronesi","year":"1988","unstructured":"Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318(18):1159\u201362. https:\/\/doi.org\/10.1056\/NEJM198805053181804 .","journal-title":"N Engl J Med"},{"key":"798_CR20","doi-asserted-by":"publisher","unstructured":"Sladden MJ, Balch C, Barzilai DA, Berg DA, Freiman A, Handiside T, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev. 2009;(4):CD004835. https:\/\/doi.org\/10.1002\/14651858.CD004835.pub2 .","DOI":"10.1002\/14651858.CD004835.pub2"},{"issue":"11","key":"798_CR21","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","volume":"49","author":"U Veronesi","year":"1982","unstructured":"Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49(11):2420\u201330.","journal-title":"Cancer."},{"issue":"4","key":"798_CR22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/archsurg.1991.01410280036004","volume":"126","author":"U Veronesi","year":"1991","unstructured":"Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126(4):438\u201341.","journal-title":"Arch Surg"},{"issue":"9","key":"798_CR23","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1809::AID-CNCR8>3.0.CO;2-6","volume":"77","author":"U Ringborg","year":"1996","unstructured":"Ringborg U, Andersson R, Eldh J, Glaumann B, Hafstrom L, Jacobsson S, et al. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer. 1996;77(9):1809\u201314. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19960501)77:9<1809::AID-CNCR8>3.0.CO;2-6 .","journal-title":"Cancer."},{"issue":"2","key":"798_CR24","first-page":"101","volume":"8","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 2001;8(2):101\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"798_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/BF02305762","volume":"3","author":"CP Karakousis","year":"1996","unstructured":"Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol. 1996;3(5):446\u201352.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"798_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","volume":"218","author":"CM Balch","year":"1993","unstructured":"Balch CM, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Drzewiecki K, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg. 1993;218(3):262\u20137 discussion 7\u20139.","journal-title":"Ann Surg"},{"issue":"8","key":"798_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa030681","volume":"350","author":"JM Thomas","year":"2004","unstructured":"Thomas JM, Newton-Bishop J, A\u2019Hern R, Coombes G, Timmons M, Evans J, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350(8):757\u201366. https:\/\/doi.org\/10.1056\/NEJMoa030681 .","journal-title":"N Engl J Med"},{"issue":"2","key":"798_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(15)00482-9","volume":"17","author":"AJ Hayes","year":"2016","unstructured":"Hayes AJ, Maynard L, Coombes G, Newton-Bishop J, Timmons M, Cook M, et al. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomized trial. Lancet Oncol. 2016;17(2):184\u201392. https:\/\/doi.org\/10.1016\/S1470-2045(15)00482-9 .","journal-title":"Lancet Oncol"},{"issue":"9803","key":"798_CR29","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0140-6736(11)61546-8","volume":"378","author":"P Gillgren","year":"2011","unstructured":"Gillgren P, Drzewiecki KT, Niin M, Gullestad HP, Hellborg H, Mansson-Brahme E, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomized, multicentre trial. Lancet. 2011;378(9803):1635\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(11)61546-8 .","journal-title":"Lancet."},{"key":"798_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ctrv.2015.10.013","volume":"42","author":"K Wheatley","year":"2016","unstructured":"Wheatley K, Wilson JS, Gaunt P, Marsden JR. Surgical excision margins in primary cutaneous melanoma: a meta-analysis and Bayesian probability evaluation. Cancer Treat Rev. 2016;42:73\u201381. https:\/\/doi.org\/10.1016\/j.ctrv.2015.10.013 .","journal-title":"Cancer Treat Rev"},{"key":"798_CR31","unstructured":"MelMarT. Melanoma margins trial investigating 1cm v 2cm Wide. Excision margins for primary cutaneous melanoma. http:\/\/www.clinicaltrials.gov\/ ."},{"key":"798_CR32","doi-asserted-by":"publisher","unstructured":"Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Thompson JF, Peach H, et al. Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study. Ann Surg Oncol. 2018;25(9):2541\u20139. https:\/\/doi.org\/10.1245\/s10434-018-6470-1 .","DOI":"10.1245\/s10434-018-6470-1"},{"issue":"3","key":"798_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1445-2197.2003.02638.x","volume":"73","author":"FC Behan","year":"2003","unstructured":"Behan FC. The keystone design perforator island flap in reconstructive surgery. ANZ J Surg. 2003;73(3):112\u201320.","journal-title":"ANZ J Surg"},{"issue":"4","key":"798_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392\u20139.","journal-title":"Arch Surg"},{"issue":"5","key":"798_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamasurg.2013.1335","volume":"148","author":"EL Jones","year":"2013","unstructured":"Jones EL, Jones TS, Pearlman NW, Gao D, Stovall R, Gajdos C, et al. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg. 2013;148(5):456\u201361. https:\/\/doi.org\/10.1001\/jamasurg.2013.1335 .","journal-title":"JAMA Surg"},{"issue":"3","key":"798_CR36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1245\/s10434-015-4912-6","volume":"23","author":"DY Lee","year":"2016","unstructured":"Lee DY, Huynh KT, Teng A, Lau BJ, Vitug S, Lee JH, et al. Predictors and survival impact of false-negative sentinel nodes in melanoma. Ann Surg Oncol. 2016;23(3):1012\u20138. https:\/\/doi.org\/10.1245\/s10434-015-4912-6 .","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"798_CR37","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1245\/s10434-007-9433-5","volume":"14","author":"C Caraco","year":"2007","unstructured":"Caraco C, Marone U, Celentano E, Botti G, Mozzillo N. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol. 2007;14(9):2662\u20137. https:\/\/doi.org\/10.1245\/s10434-007-9433-5 .","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"798_CR38","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1245\/s10434-013-2905-x","volume":"20","author":"DM Gilmore","year":"2013","unstructured":"Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL, et al. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol. 2013;20(7):2357\u201363. https:\/\/doi.org\/10.1245\/s10434-013-2905-x .","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"798_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10549-016-3809-9","volume":"157","author":"A Karakatsanis","year":"2016","unstructured":"Karakatsanis A, Christiansen PM, Fischer L, Hedin C, Pistioli L, Sund M, et al. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies. Breast Cancer Res Treat. 2016;157(2):281\u201394. https:\/\/doi.org\/10.1007\/s10549-016-3809-9 .","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"798_CR40","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622\u201334. https:\/\/doi.org\/10.1200\/JCO.2001.19.16.3622 .","journal-title":"J Clin Oncol"},{"issue":"13","key":"798_CR41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307\u201317. https:\/\/doi.org\/10.1056\/NEJMoa060992 .","journal-title":"N Engl J Med"},{"issue":"4","key":"798_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724.","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36(4):399\u2013413. https:\/\/doi.org\/10.1200\/JCO.2017.75.7724.","journal-title":"J Clin Oncol"},{"issue":"35","key":"798_CR43","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","volume":"31","author":"D Han","year":"2013","unstructured":"Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol. 2013;31(35):4387\u201393. https:\/\/doi.org\/10.1200\/JCO.2013.50.1114 .","journal-title":"J Clin Oncol"},{"issue":"13","key":"798_CR44","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1245\/s10434-016-5137-z","volume":"23","author":"E Cordeiro","year":"2016","unstructured":"Cordeiro E, Gervais MK, Shah PS, Look Hong NJ, Wright FC. Sentinel lymph node biopsy in thin cutaneous melanoma: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(13):4178\u201388. https:\/\/doi.org\/10.1245\/s10434-016-5137-z .","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"798_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaad.2015.09.014","volume":"74","author":"H Wat","year":"2016","unstructured":"Wat H, Senthilselvan A, Salopek TG. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas. J Am Acad Dermatol. 2016;74(1):94\u2013101. https:\/\/doi.org\/10.1016\/j.jaad.2015.09.014 .","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"798_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"\u2022 Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa1310460 Randomized controlled trial comparing SNB with nodal observation.","journal-title":"N Engl J Med"},{"issue":"11","key":"798_CR47","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1245\/s10434-014-3954-5","volume":"21","author":"SD Kachare","year":"2014","unstructured":"Kachare SD, Brinkley J, Wong JH, Vohra NA, Zervos EE, Fitzgerald TL. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma. Ann Surg Oncol. 2014;21(11):3377\u201385. https:\/\/doi.org\/10.1245\/s10434-014-3954-5 .","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"798_CR48","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1245\/s10434-015-4766-y","volume":"23","author":"EK Bartlett","year":"2016","unstructured":"Bartlett EK, Peters MG, Blair A, Etherington MS, Elder DE, Xu XG, et al. Identification of patients with intermediate thickness melanoma at low risk for sentinel lymph node positivity. Ann Surg Oncol. 2016;23(1):250\u20136. https:\/\/doi.org\/10.1245\/s10434-015-4766-y .","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"798_CR49","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s00259-017-3674-8","volume":"44","author":"A Forschner","year":"2017","unstructured":"Forschner A, Olthof SC, Guckel B, Martus P, Vach W, la Fougere C, et al. Impact of (18)F-FDG-PET\/CT on surgical management in patients with advanced melanoma: an outcome based analysis. Eur J Nucl Med Mol Imaging. 2017;44(8):1312\u20138. https:\/\/doi.org\/10.1007\/s00259-017-3674-8 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"798_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/ans.13286","volume":"86","author":"JM Roy","year":"2016","unstructured":"Roy JM, Whitfield RJ, Gill PG. Review of the role of sentinel node biopsy in cutaneous head and neck melanoma. ANZ J Surg. 2016;86(5):348\u201355. https:\/\/doi.org\/10.1111\/ans.13286 .","journal-title":"ANZ J Surg"},{"issue":"9","key":"798_CR51","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1001\/archsurg.139.9.1002","volume":"139","author":"TS Menes","year":"2004","unstructured":"Menes TS, Schachter J, Steinmetz AP, Hardoff R, Gutman H. Lymphatic drainage to the popliteal basin in distal lower extremity malignant melanoma. Arch Surg. 2004;139(9):1002\u20136. https:\/\/doi.org\/10.1001\/archsurg.139.9.1002 .","journal-title":"Arch Surg"},{"issue":"1","key":"798_CR52","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jamcollsurg.2011.01.062","volume":"213","author":"ST Steen","year":"2011","unstructured":"Steen ST, Kargozaran H, Moran CJ, Shin-Sim M, Morton DL, Faries MB. Management of popliteal sentinel nodes in melanoma. J Am Coll Surg. 2011;213(1):180\u20136; discussion 6\u20137. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2011.01.062 .","journal-title":"J Am Coll Surg"},{"issue":"10","key":"798_CR53","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archsurg.135.10.1168","volume":"135","author":"RF Uren","year":"2000","unstructured":"Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000;135(10):1168\u201372.","journal-title":"Arch Surg"},{"issue":"3","key":"798_CR54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","volume":"242","author":"DL Morton","year":"2005","unstructured":"Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242(3):302\u201311 discussion 11\u20133.","journal-title":"Ann Surg"},{"issue":"4","key":"798_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/archderm.136.4.511","volume":"136","author":"DA Wrone","year":"2000","unstructured":"Wrone DA, Tanabe KK, Cosimi AB, Gadd MA, Souba WW, Sober AJ. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol. 2000;136(4):511\u20134.","journal-title":"Arch Dermatol"},{"issue":"6","key":"798_CR56","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"\u2022 Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomized, phase 3 trial. Lancet Oncol. 2016;17(6):757\u201367. https:\/\/doi.org\/10.1016\/S1470-2045(16)00141-8 Randomized controlled trial comparing CLND with observation, study stopped prematurely.","journal-title":"Lancet Oncol"},{"issue":"23","key":"798_CR57","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"\u2022\u2022 Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1613210 Randomized controlled trial comparing CLND with observation.","journal-title":"N Engl J Med"},{"issue":"9","key":"798_CR58","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1056\/NEJMc1708918.","volume":"377","author":"AFD Falk Delgado","year":"2017","unstructured":"Falk Delgado AFD. A. Melanoma sentinel-node metastasis. N Engl J Med. 2017;377(9):891\u20132. https:\/\/doi.org\/10.1056\/NEJMc1708918.","journal-title":"N Engl J Med"},{"issue":"12","key":"798_CR59","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.21873\/anticanres.12143","volume":"37","author":"AF Delgado","year":"2017","unstructured":"Delgado AF, Delgado AF. Complete lymph node dissection in melanoma: a systematic review and meta-analysis. Anticancer Res. 2017;37(12):6825\u20139. https:\/\/doi.org\/10.21873\/anticanres.12143 .","journal-title":"Anticancer Res"},{"issue":"19","key":"798_CR60","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","volume":"377","author":"GV Long","year":"2017","unstructured":"\u2022\u2022 Long GV, Hauschild A, Santinami M, Atkinson V, Mandala M, Chiarion-Sileni V, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377(19):1813\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1708539 Adjuvant treatment in resected malignant melanoma.","journal-title":"N Engl J Med"},{"issue":"19","key":"798_CR61","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"\u2022\u2022 Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377(19):1824\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1709030 Adjuvant treatment in resected malignant melanoma.","journal-title":"N Engl J Med"},{"issue":"10","key":"798_CR62","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1245\/s10434-009-0602-6","volume":"16","author":"M Vries de","year":"2009","unstructured":"de Vries M, Hoekstra HJ, Hoekstra-Weebers JE. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16(10):2840\u20137. https:\/\/doi.org\/10.1245\/s10434-009-0602-6 .","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"798_CR63","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.ejso.2017.07.003","volume":"43","author":"JA Moody","year":"2017","unstructured":"Moody JA, Botham SJ, Dahill KE, Wallace DL, Hardwicke JT. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - a systematic review of the literature. Eur J Surg Oncol. 2017;43(9):1760\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2017.07.003 .","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"798_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2133.2010.09883.x","volume":"163","author":"JR Marsden","year":"2010","unstructured":"Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, et al. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol. 2010;163(2):238\u201356. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09883.x .","journal-title":"Br J Dermatol"},{"issue":"7","key":"798_CR65","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1245\/s10434-017-5803-9","volume":"24","author":"MF Madu","year":"2017","unstructured":"Madu MF, Deken MM, van der Hage JA, Jozwiak K, Wouters M, van Akkooi ACJ. Isolated limb perfusion for melanoma is safe and effective in elderly patients. Ann Surg Oncol. 2017;24(7):1997\u20132005. https:\/\/doi.org\/10.1245\/s10434-017-5803-9 .","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"798_CR66","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","volume":"15","author":"D Moreno-Ramirez","year":"2010","unstructured":"Moreno-Ramirez D, de la Cruz-Merino L, Ferrandiz L, Villegas-Portero R, Nieto-Garcia A. Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist. 2010;15(4):416\u201327. https:\/\/doi.org\/10.1634\/theoncologist.2009-0325 .","journal-title":"Oncologist."},{"issue":"7","key":"798_CR67","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1245\/s10434-016-5150-2","volume":"23","author":"LA Dossett","year":"2016","unstructured":"Dossett LA, Ben-Shabat I, Olofsson Bagge R, Zager JS. Clinical response and regional toxicity following isolated limb infusion compared with isolated limb perfusion for in-transit melanoma. Ann Surg Oncol. 2016;23(7):2330\u20135. https:\/\/doi.org\/10.1245\/s10434-016-5150-2 .","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"798_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/2326-6066.CIR-17-0356","volume":"6","author":"CE Ariyan","year":"2018","unstructured":"Ariyan CE, Brady MS, Siegelbaum RH, Hu J, Bello DM, Rand J, et al. Robust antitumor responses result from local chemotherapy and CTLA-4 blockade. Cancer Immunol Res. 2018;6(2):189\u2013200. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0356 .","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"798_CR69","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1067\/j.cpsurg.2011.02.002","volume":"48","author":"A Sanki","year":"2011","unstructured":"Sanki A, Kroon HM, Kam PC, Thompson JF. Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. Curr Probl Surg. 2011;48(6):371\u2013430. https:\/\/doi.org\/10.1067\/j.cpsurg.2011.02.002 .","journal-title":"Curr Probl Surg"},{"issue":"7639","key":"798_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115\u20138. https:\/\/doi.org\/10.1038\/nature21056 .","journal-title":"Nature."},{"issue":"1","key":"798_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/j.seminoncol.2010.11.012","volume":"38","author":"A Zhu","year":"2011","unstructured":"Zhu A, Lee D, Shim H. Metabolic positron emission tomography imaging in cancer detection and therapy response. Semin Oncol. 2011;38(1):55\u201369. https:\/\/doi.org\/10.1053\/j.seminoncol.2010.11.012 .","journal-title":"Semin Oncol"},{"key":"798_CR72","doi-asserted-by":"publisher","unstructured":"Iyer RB, Balachandran A, Devine CE. PET\/CT and cross sectional imaging of gynecologic malignancy. Cancer Imaging 2007;7 (Spec no. A):S130\u2013S138. https:\/\/doi.org\/10.1102\/1470-7330.2007.9015 .","DOI":"10.1102\/1470-7330.2007.9015"},{"issue":"2","key":"798_CR73","first-page":"248","volume":"42","author":"A Dimitrakopoulou-Strauss","year":"2001","unstructured":"Dimitrakopoulou-Strauss A, Strauss LG, Burger C. Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. J Nucl Med. 2001;42(2):248\u201356.","journal-title":"J Nucl Med"},{"issue":"6","key":"798_CR74","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1002\/mrm.26974","volume":"79","author":"S Skare","year":"2018","unstructured":"Skare S, Sprenger T, Norbeck O, Ryden H, Blomberg L, Avventi E, et al. A 1-min full brain MR exam using a multicontrast EPI sequence. Magn Reson Med. 2018;79(6):3045\u201354. https:\/\/doi.org\/10.1002\/mrm.26974 .","journal-title":"Magn Reson Med"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-019-0798-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-019-0798-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-019-0798-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:20:13Z","timestamp":1694834413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-019-0798-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1007\/s11912-019-0798-y","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"26 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"54"}}